Skip to main content
Caplight Logo









Intima Bioscience

Intima Bioscience

Private
New York City, New YorkHealthcare & Life Scienceshttps://intimabioscience.com

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Intima Bioscience operates in Healthcare & Life Sciences and is based in New York City, New York. It was founded in 2014.

Intima Bioscience is a biotechnology company that develops gene and cell therapies for the treatment of solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Intima Bioscience Comparables

Compare Intima Bioscience with similar companies based on industry and business-model similarity.

Intima Bioscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Affini-T Therapeutics
82%
Obsidian Therapeutics
81%
Grit Biotherapeutics
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Intima Bioscience Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Intima Bioscience. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 103% MoM, reaching 1.2K.

  • May 4, 2025

    Monthly visitors grew 159% MoM, reaching 1.2K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Intima Bioscience Filings

Explore SEC and related filing metadata, where available.

Intima Bioscience filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Intima Bioscience's valuation, stock price, and market status.

Is Intima Bioscience a public or private company?

Intima Bioscience is a private company.

What is the current stock price of Intima Bioscience?

Intima Bioscience is a private company, so its shares have no public market price. Caplight tracks Intima Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Intima Bioscience worth (valuation)?

Valuation information for Intima Bioscience is not publicly available.

Can I buy Intima Bioscience stock?

Intima Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Intima Bioscience's last funding round?

Funding round information for Intima Bioscience is not publicly available.

Who are the main investors in Intima Bioscience?

Investor information for Intima Bioscience is not publicly disclosed.

Will Intima Bioscience IPO soon?

No public IPO plans have been announced for Intima Bioscience.

How can I track Intima Bioscience secondary market activity?

Caplight tracks bids, offers, and trades in Intima Bioscience's shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Employee Range5
Year Founded2014
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?